Spirometry in Smokers and Non-smokers: A Comparative Study
Abstract
Introduction: Spirometry is the physiological test that measures how an individual breathes air volumes as a function of time. Smoking produces an increase in epithelial damage, cellular inflammatory infiltrates, muscles and fibrosis in respiratory airways and is responsible for acute respiratory various illnesses. Early identification of reduction in lung function of smokers by spirometry can be very important in order to encourage them to stop smoking.
Methods: This study included a total of 106 individuals, 51 were smokers and 55 were non-smokers. The participants performed spirometry in the sitting position by open circuit method. Parameters of spirometry FVC, FEV1, FEV1/FVC and PEFR were recorded in the form of a percentage of predicted.
Results: The mean FVC in smokers and non-smokers was 99.98±9.88% and 102.97±8.03% respectively (p=0.092). The mean FEV1 in smokers and non-smokers was 99.65±9.61% and 104.58±10.03% respectively (p=0.011). The mean FEV1/FVC ratio in smokers and non-smokers was 103.25±4.60% and 105.57±5.10% respectively (p=0.016). The mean PEFR in smokers and non-smokers was 102.11±8.40% and 106.01±10.62% respectively (p=0.038).
The mean FVC in smokers was less than in non-smokers (99.98±9.88% and 102.97±8.03%, p=0.092). FEV1, (99.65±9.61% vs 104.58±10.03%, p=0.011) FEV1/FVC ratio (103.25±4.60% vs 105.57±5.10%, p=0.016) and PEFR (102.11±8.40% vs 106.01±10.62%, p=0.038) were significantly lesser in smokers than non-smokers.
Conclusion: The spirometry parameters of pulmonary function were poorer in the smoker group. Spirometry can be useful in detecting a reduction in pulmonary function before the appearance of any symptoms or before pulmonary functions become significantly abnormal.
Keywords: COPD, FEV1, FVC, PEFR, pulmonary function test, smoking, spirometry
Downloads
Published
How to Cite
Issue
Section
License
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/